120 related articles for article (PubMed ID: 653315)
1. Platelet activation: a new biological activity of guinea-pig C3a anaphylatoxin.
Becker S; Meuer S; Hadding U; Bitter-Suermann D
Scand J Immunol; 1978; 7(2):173-80. PubMed ID: 653315
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of high-affinity binding sites for C3a anaphylatoxin on guinea-pig platelets.
Becker S; Hadding U; Schorlemmer HU; Bitter-Suermann D
Scand J Immunol; 1978; 8(6):551-5. PubMed ID: 734357
[TBL] [Abstract][Full Text] [Related]
3. Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion.
Meuer S; Hugli TE; Andreatta RH; Hadding U; Bitter-Suermann D
Inflammation; 1981 Dec; 5(4):263-73. PubMed ID: 6976935
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of a specific C3a receptor on guinea pig platelets.
Fukuoka Y; Hugli TE
J Immunol; 1988 May; 140(10):3496-501. PubMed ID: 3283237
[TBL] [Abstract][Full Text] [Related]
5. Platelet-serotonin release by C3a and C5a: two independent pathways of activation.
Meuer S; Ecker U; Hadding U; Bitter-Suermann D
J Immunol; 1981 Apr; 126(4):1506-9. PubMed ID: 7204973
[TBL] [Abstract][Full Text] [Related]
6. C3a induced activation and stimulus specific reversible desensitization of guinea pig platelets.
Zanker B; Rasokat H; Hadding U; Bitter-Suermann D
Agents Actions Suppl; 1982; 11():147-57. PubMed ID: 6983827
[TBL] [Abstract][Full Text] [Related]
7. Synthetic C3a analogs as specific inhibitors of C3a activity.
Meuer S; Hadding U; Andreatta R; Bitter-Suermann D
Immunopharmacology; 1981 Sep; 3(3):275-80. PubMed ID: 6975766
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary injury induced by C3a and C5a anaphylatoxins.
Stimler NP; Hugli TE; Bloor CM
Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
[TBL] [Abstract][Full Text] [Related]
9. Immunopharmacology of anaphylatoxin-induced bronchoconstrictor responses.
Stimler-Gerard NP
Complement; 1986; 3(3):137-51. PubMed ID: 3026723
[TBL] [Abstract][Full Text] [Related]
10. Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.
Marceau F; Hugli TE
J Pharmacol Exp Ther; 1984 Sep; 230(3):749-54. PubMed ID: 6332191
[TBL] [Abstract][Full Text] [Related]
11. Induction of platelet aggregation by the complement-derived peptides C3a and C5a.
Grossklaus C; Damerau B; Lemgo E; Vogt W
Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct; 295(1):71-6. PubMed ID: 1004644
[TBL] [Abstract][Full Text] [Related]
12. Induction of thromboxane release from macrophages by anaphylatoxic peptide C3a of complement and synthetic hexapeptide C3a 72-77.
Hartung HP; Bitter-Suermann D; Hadding U
J Immunol; 1983 Mar; 130(3):1345-9. PubMed ID: 6600482
[TBL] [Abstract][Full Text] [Related]
13. Synthetic peptides with the biological activities and specificity of human C3a anaphylatoxin.
Hugli TE; Erickson BW
Proc Natl Acad Sci U S A; 1977 May; 74(5):1826-30. PubMed ID: 266705
[TBL] [Abstract][Full Text] [Related]
14. Low zone desensitization: a stimulus-specific control mechanism of cell response. Investigations on anaphylatoxin-induced platelet secretion.
Meuer S; Zanker B; Hadding U; Bitter-Suermann D
J Exp Med; 1982 Mar; 155(3):698-710. PubMed ID: 6977607
[TBL] [Abstract][Full Text] [Related]
15. Cardiac anaphylaxis. Complement activation as an amplification system.
del Balzo U; Polley MJ; Levi R
Circ Res; 1989 Sep; 65(3):847-57. PubMed ID: 2475275
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis and quantification of the complement C3 derived anaphylatoxin C3a with a monoclonal antibody.
Burger R; Bader A; Kirschfink M; Rother U; Schrod L; Wörner I; Zilow G
Clin Exp Immunol; 1987 Jun; 68(3):703-11. PubMed ID: 3498585
[TBL] [Abstract][Full Text] [Related]
17. The anaphylatoxic peptide C3a of guinea pig complement. I. Purification, physicochemical and antigenetic properties.
Meuer S; Becker S; Hadding U; Bitter-Suermann D
Z Immunitatsforsch Immunobiol; 1978 Mar; 154(2):135-46. PubMed ID: 77089
[TBL] [Abstract][Full Text] [Related]
18. Activation of the third complement component (C3) and C3a generation in cardiac anaphylaxis: histamine release and associated inotropic and chronotropic effects.
del Balzo U; Polley MJ; Levi R
J Pharmacol Exp Ther; 1988 Sep; 246(3):911-6. PubMed ID: 2458450
[TBL] [Abstract][Full Text] [Related]
19. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
[TBL] [Abstract][Full Text] [Related]
20. Complement anaphylatoxins in idiopathic mixed cryoglobulinemia.
Miadonna A; Leggieri E; Tedeschi A; Cottini M; Invernizzi F; Froldi M; Zanussi C
Int Arch Allergy Appl Immunol; 1985; 76(2):120-5. PubMed ID: 3967939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
